Post-Transplant Cardiovascular Disease

Area of Science:

• Nephrology
• Cardiology
• Transplantation Medicine

Background:

• Cardiovascular disease (CVD) is a major cause of mortality and morbidity in kidney transplant recipients.
• Pre-existing and post-transplant cardiovascular risk factors are exacerbated by immunosuppressive therapy.
• Common post-transplant cardiovascular complications include coronary artery disease, heart failure, and arrhythmias.

Purpose of the Study:

• To review and discuss optimal strategies for identifying and treating cardiovascular risk factors in kidney transplant recipients.
• To highlight emerging therapeutic options, such as sodium-glucose cotransporter 2 inhibitors, for managing post-transplant diabetes and CVD.
• To outline approaches for screening, treatment, and prevention of cardiac disease post-kidney transplantation.

Main Methods:

• Review of current literature on cardiovascular risk factors and management in kidney transplant recipients.
• Discussion of traditional and nontraditional cardiovascular risk factors.
• Exploration of screening protocols, treatment guidelines, and preventive measures for post-transplant cardiac disease.

Main Results:

• Identification of key cardiovascular risk factors, both pre- and post-transplant.
• Discussion of the impact of immunosuppression on cardiovascular health.
• Emerging role of sodium-glucose cotransporter 2 inhibitors in managing comorbid diabetes and CVD.

Conclusions:

• Comprehensive management of cardiovascular risk factors is essential for improving long-term outcomes in kidney transplant recipients.
• Further research is needed to establish optimal treatment goals, medication choices, and the role of biomarkers and screening interventions.
• Proactive screening and tailored treatment strategies are vital for preventing and managing post-transplant cardiac disease.